DKL:NYSEDelek Logistics Partners, L.P. Analysis
Data as of 2026-03-29 - not real-time
$53.12
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Delek Logistics Partners (DKL) trades at $53.12, comfortably above its 20‑day SMA (53.29) and well above the 200‑day SMA (46.51), indicating a longer‑term bullish bias. However, the MACD histogram is negative (-0.046) and the signal line is bearish, while RSI sits at a neutral 50.6, suggesting short‑term momentum is fading. Fundamentally, the company posted a 22% revenue growth year‑over‑year and a solid 33% gross margin, but free cash flow remains negative (-$142 M) and leverage is extreme (debt‑to‑equity > 38,000%). The dividend yield is attractive at 8.41% but the payout ratio exceeds 130%, raising questions about sustainability. The DCF‑derived fair value of $56.27 implies modest upside (~6%) versus the current price, while the market assigns a low beta (0.57) and the sector is experiencing moderate risk.
The recent integration of H2O and Gravity assets expands the Permian footprint and supports the 52‑quarter distribution streak, yet the latest earnings missed expectations and the decreasing volume trend signals waning investor enthusiasm. Balancing the undervalued price relative to peers (P/E 16 vs industry 24) against cash‑flow strain and high leverage suggests a cautious stance: hold with a watch on cash‑flow generation and dividend coverage.
The recent integration of H2O and Gravity assets expands the Permian footprint and supports the 52‑quarter distribution streak, yet the latest earnings missed expectations and the decreasing volume trend signals waning investor enthusiasm. Balancing the undervalued price relative to peers (P/E 16 vs industry 24) against cash‑flow strain and high leverage suggests a cautious stance: hold with a watch on cash‑flow generation and dividend coverage.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD crossover
- Earnings miss and negative free cash flow
- Decreasing volume trend
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Revenue growth and integration of new assets
- Undervalued relative to DCF and peers
- High leverage and dividend coverage risk
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained distribution streak but payout > earnings
- Long‑term bullish trend (price above SMA200)
- Sector volatility and regulatory exposure
Key Metrics & Analysis
Financial Health
Revenue Growth21.90%
Profit Margin17.41%
P/E Ratio16.1
ROE847.51%
ROA4.41%
Debt/Equity38920.46
P/B Ratio466.0
Op. Cash Flow$237.1M
Free Cash Flow$-142271248
Industry P/E24.0
Technical Analysis
TrendBullish
RSI50.6
Support$50.88
Resistance$54.91
MA 20$53.29
MA 50$52.26
MA 200$46.51
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98
Valuation
Fair Value$56.27
Target Price$49.00
Upside/Downside-7.76%
GradeUndervalued
TypeBlend
Dividend Yield8.41%
Risk Assessment
Beta0.57
Volatility27.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.